City

Boston (1)

Chicago (1)

Rochester (1)

Condition

Recurrent Malignant Mesothelioma (2)

Stage IA Malignant Mesothelioma (2)

Stage IB Malignant Mesothelioma (2)

Stage II Malignant Mesothelioma (2)

Stage III Malignant Mesothelioma (2)

Stage IV Malignant Mesothelioma (2)

Epithelial Mesothelioma (1)

Sarcomatous Mesothelioma (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Mayo Clinic (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

laboratory biomarker analysis (2)

computed tomography (1)

oncolytic measles virus encoding thyroidal sodium iodide symporter (1)

single photon emission computed tomography (1)

sorafenib tosylate (1)

Study Documents

Intervention Type

other (2)

biological (1)

drug (1)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

stage ib malignant mesothelioma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Malignant Mesothelioma, Stage IA Malignant Mesothelioma, Stage IB Malignant Mesothelioma Trial in Rochester

Completed

Recurrent Malignant Mesothelioma
+5 more

oncolytic measles virus encoding thyroidal sodium iodide symporter
+3 more

Rochester, Minnesota

Mayo Clinic

Jan 8, 2021

Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma Trial in Chicago, Boston (sorafenib

Completed

Epithelial Mesothelioma
+7 more

sorafenib tosylate
laboratory biomarker analysis

Chicago, Illinois
+1 more

Jun 4, 2013